EP0643706A4 - Verbindungen, zusammensetzungen und methoden um biologisch aktive substanzen anoberfl chenmembrane von biopartikeln zu binden. - Google Patents
Verbindungen, zusammensetzungen und methoden um biologisch aktive substanzen anoberfl chenmembrane von biopartikeln zu binden.Info
- Publication number
- EP0643706A4 EP0643706A4 EP19930900600 EP93900600A EP0643706A4 EP 0643706 A4 EP0643706 A4 EP 0643706A4 EP 19930900600 EP19930900600 EP 19930900600 EP 93900600 A EP93900600 A EP 93900600A EP 0643706 A4 EP0643706 A4 EP 0643706A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- bio
- compositions
- particles
- compounds
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1258—Pills, tablets, lozenges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dispersion Chemistry (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79893691A | 1991-11-27 | 1991-11-27 | |
| US798936 | 1991-11-27 | ||
| US07/884,432 US5667764A (en) | 1988-05-02 | 1992-05-15 | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| US884432 | 1992-05-15 | ||
| PCT/US1992/010076 WO1993011120A1 (en) | 1991-11-27 | 1992-11-24 | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0643706A4 true EP0643706A4 (de) | 1994-12-27 |
| EP0643706A1 EP0643706A1 (de) | 1995-03-22 |
Family
ID=27122052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP93900600A Withdrawn EP0643706A1 (de) | 1991-11-27 | 1992-11-24 | Verbindungen, zusammensetzungen und methoden um biologisch aktive substanzen anoberfl chenmembrane von biopartikeln zu binden |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0643706A1 (de) |
| JP (2) | JP3682974B2 (de) |
| CN (1) | CN1074911A (de) |
| AU (2) | AU3221993A (de) |
| CA (1) | CA2124329C (de) |
| IL (1) | IL103874A0 (de) |
| MX (1) | MX9206844A (de) |
| NZ (1) | NZ245271A (de) |
| PH (1) | PH31676A (de) |
| WO (1) | WO1993011120A1 (de) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2472404A1 (en) † | 1993-07-19 | 1995-02-02 | Angiotech Pharmaceuticals, Inc. | Combination of stent and anti-angiogenic factor |
| EP1118325B2 (de) | 1993-07-29 | 2010-01-06 | The United States of America, represented by the Secretary, Department of Health and Human Services | Verwendung von Paclitaxel und seinen Derivaten zur Herstellung eines Medikaments für die Behandlung von Restenose |
| US5480901A (en) * | 1994-10-07 | 1996-01-02 | Zynaxis, Inc. | Method for reducing unwanted cellular adhesions |
| US6492332B1 (en) | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
| US6004536A (en) * | 1995-11-14 | 1999-12-21 | Molecular Probes, Inc. | Lipophilic cyanine dyes with enchanced aqueous solubilty |
| WO1997024459A1 (en) * | 1995-12-29 | 1997-07-10 | Phanos Technologoes, Inc. | Method for reducing unwanted cellular adhesions |
| US5871436A (en) * | 1996-07-19 | 1999-02-16 | Advanced Cardiovascular Systems, Inc. | Radiation therapy method and device |
| US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
| WO1998043618A2 (en) * | 1997-03-31 | 1998-10-08 | Neorx Corporation | Use of cytoskeletal inhibitors for the prevention of restenosis |
| US7208011B2 (en) | 2001-08-20 | 2007-04-24 | Conor Medsystems, Inc. | Implantable medical device with drug filled holes |
| US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
| US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
| US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
| US7045305B1 (en) * | 1998-04-08 | 2006-05-16 | The Regents Of The University Of California | Methods and reagents for targeting organic compounds to selected cellular locations |
| WO1999055396A1 (en) | 1998-04-27 | 1999-11-04 | Surmodics, Inc. | Bioactive agent release coating |
| US6120847A (en) * | 1999-01-08 | 2000-09-19 | Scimed Life Systems, Inc. | Surface treatment method for stent coating |
| US6333347B1 (en) | 1999-01-29 | 2001-12-25 | Angiotech Pharmaceuticals & Advanced Research Tech | Intrapericardial delivery of anti-microtubule agents |
| US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
| US6156373A (en) | 1999-05-03 | 2000-12-05 | Scimed Life Systems, Inc. | Medical device coating methods and devices |
| MXPA02001902A (es) * | 1999-08-23 | 2003-04-10 | Angiogene Inc | Dispositivo radioactivamente cubierto y metodo para elaborar el mismo para la prevencion de restenosis. |
| CO5261573A1 (es) | 1999-11-19 | 2003-03-31 | Novartis Ag | Derivados de benzoxa y bezotiazol, compuesto y composicion farmaceutica que los contiene y proceso para la preparacion de la mencionada composicion |
| IT1319168B1 (it) * | 2000-03-17 | 2003-09-26 | Indena Spa | Derivati di condensazione ad attivita' antitumorale, loro metodo dipreparazione e formulazioni che li contengono. |
| DE60133053T2 (de) | 2000-10-16 | 2009-02-26 | Conor Medsystems, Inc., Menlo Park | Ausdehnbare medizinische Vorrichtung zur Abgabe eines nützlichen Agens |
| DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| US6613083B2 (en) | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
| US7056338B2 (en) | 2003-03-28 | 2006-06-06 | Conor Medsystems, Inc. | Therapeutic agent delivery device with controlled therapeutic agent release rates |
| DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| US7776529B2 (en) | 2003-12-05 | 2010-08-17 | Life Technologies Corporation | Methine-substituted cyanine dye compounds |
| JP2007532187A (ja) | 2004-04-06 | 2007-11-15 | サーモディクス，インコーポレイティド | 生物活性物質のためのコーティング組成物 |
| USD516723S1 (en) | 2004-07-06 | 2006-03-07 | Conor Medsystems, Inc. | Stent wall structure |
| DE602005025911D1 (de) | 2004-11-22 | 2011-02-24 | Ge Healthcare As | Kontrastmittel für eine extrazelluläre matrix |
| US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
| JP5306811B2 (ja) | 2005-05-11 | 2013-10-02 | ライフ テクノロジーズ コーポレーション | ２本鎖ｄｎａへの高い選択性を有する蛍光化学物質及びそれらの使用 |
| US9198968B2 (en) | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| US8257722B2 (en) | 2008-09-15 | 2012-09-04 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| US8114429B2 (en) | 2008-09-15 | 2012-02-14 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
| US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
| CN105745266B (zh) * | 2013-11-26 | 2019-05-17 | 住友化学株式会社 | 橡胶组合物及硫化助剂 |
| US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
| EP3101012A1 (de) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | Neue gadoliniumchelat-verbindung zur verwendung in der magnetresonanzbildgebung |
| ES2814555T3 (es) | 2016-11-28 | 2021-03-29 | Bayer Pharma AG | Compuestos de quelato de gadolinio con alta relaxividad para usar en la obtención de imágenes por resonancia magnética |
| KR102934987B1 (ko) | 2018-11-23 | 2026-03-09 | 바이엘 악티엔게젤샤프트 | 조영 매체의 제형 및 그의 제조 방법 |
| JP7423888B2 (ja) * | 2019-11-22 | 2024-01-30 | 株式会社同仁化学研究所 | 脂質二分子膜染色用色素及びそれを用いた脂質二分子膜の染色方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
| EP0047470B1 (de) * | 1980-09-02 | 1985-04-24 | Fuji Photo Film Co., Ltd. | Verfahren zur immunochemischen Bestimmung |
| US4501728A (en) * | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4751219A (en) * | 1985-02-05 | 1988-06-14 | Nederlandse Centrale Organisatie Voor Toegepast-Natuur-Wetenschappelijk Onderzoek | Synthetic glycolipides, a process for the preparation thereof and several uses for these synthetic glycolipides |
| US4783401A (en) * | 1986-10-31 | 1988-11-08 | Smithkline Beckman Corporation | Viable cell labelling |
| US4762701A (en) * | 1986-10-31 | 1988-08-09 | Smithkline Beckman Corporation | In vivo cellular tracking |
| US4906749A (en) * | 1987-06-30 | 1990-03-06 | Viomedics Inc. | Cyclic anhydride derivatives of chromophors |
| EP0396626A1 (de) * | 1988-01-19 | 1990-11-14 | Board Of Regents, The University Of Texas System | Glycoside, sie enthaltende liposome und ihre verwendung |
| ATE145337T1 (de) * | 1988-05-02 | 1996-12-15 | Phanos Tech Inc | Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen |
| US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
-
1992
- 1992-11-24 EP EP93900600A patent/EP0643706A1/de not_active Withdrawn
- 1992-11-24 AU AU32219/93A patent/AU3221993A/en not_active Abandoned
- 1992-11-24 JP JP51019093A patent/JP3682974B2/ja not_active Expired - Lifetime
- 1992-11-24 WO PCT/US1992/010076 patent/WO1993011120A1/en not_active Ceased
- 1992-11-24 CA CA002124329A patent/CA2124329C/en not_active Expired - Lifetime
- 1992-11-25 NZ NZ245271A patent/NZ245271A/en unknown
- 1992-11-25 IL IL103874A patent/IL103874A0/xx unknown
- 1992-11-26 PH PH45327A patent/PH31676A/en unknown
- 1992-11-26 CN CN92115176A patent/CN1074911A/zh active Pending
- 1992-11-27 MX MX9206844A patent/MX9206844A/es unknown
-
1997
- 1997-04-30 AU AU19914/97A patent/AU1991497A/en not_active Abandoned
-
2002
- 2002-07-01 JP JP2002192417A patent/JP4095847B2/ja not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| No further relevant documents disclosed * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL103874A0 (en) | 1993-04-04 |
| CA2124329C (en) | 2008-11-18 |
| NZ245271A (en) | 1996-03-26 |
| CA2124329A1 (en) | 1993-06-10 |
| CN1074911A (zh) | 1993-08-04 |
| JP3682974B2 (ja) | 2005-08-17 |
| EP0643706A1 (de) | 1995-03-22 |
| MX9206844A (es) | 1993-07-01 |
| JP4095847B2 (ja) | 2008-06-04 |
| AU1991497A (en) | 1997-07-10 |
| AU3221993A (en) | 1993-06-28 |
| WO1993011120A1 (en) | 1993-06-10 |
| JPH08502719A (ja) | 1996-03-26 |
| JP2003026657A (ja) | 2003-01-29 |
| PH31676A (en) | 1999-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0643706A4 (de) | Verbindungen, zusammensetzungen und methoden um biologisch aktive substanzen anoberfl chenmembrane von biopartikeln zu binden. | |
| IL103282A0 (en) | Substituted 4-alkoxypyrimidines,process for their preparation,compositions containing them,and their use as pesticides | |
| IL63968A0 (en) | Aminoalkylfuran derivative,its preparation and pharmaceutical compositions containing it | |
| PL310992A1 (en) | Pharmaceutical composition containing lipophylic pharmaceutical substances | |
| GB9016299D0 (en) | Binding substances | |
| GB8906682D0 (en) | Composition for desorbing bacteria | |
| IL91361A0 (en) | Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL76176A (en) | Pharmaceutical compositions containing ethylenediamine monoamide derivatives,certain such novel compounds and their preparation | |
| OA08608A (en) | Pestical compositions and process for preparation thereof. | |
| IL81833A0 (en) | Renin inhibitors,their preparation and pharmaceutical compositions containing them | |
| AU5046996A (en) | Apparatus for adding flavour materials to beverages | |
| IL104099A0 (en) | Imidazoquinazoline compounds,their preparation and pharmaceutical compositions containing them | |
| ZA917429B (en) | 2-phenylpyrimidines,processes for their preparation,compositions containing them,and their use as fungicides | |
| ZA917428B (en) | 4-anilinopyrimidines,processes for their preparation,compositions containing them,and their use as fungicides | |
| EP0493611A4 (en) | Composition for functional food prepared from licorice extract | |
| IL70664A0 (en) | Novel condensed pyrrole derivatives,process for their preparation and pharmaceutical compositions containing the same | |
| IL99637A0 (en) | 5h-benzodiazepine derivative,its preparation and pharmaceutical compositions containing it | |
| JPS6420277A (en) | Aroma-containing ink composition | |
| ZA929179B (en) | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles. | |
| HU895450D0 (en) | Process for the preparation of antiflatulent pharmaceutical composition containing activated polydimethylsiloxane in solid dispersion | |
| EP0150206A4 (de) | Pyridinyl-2-pyrimidinamine verwendbar als herztonikum und deren herstellung. | |
| AU1755392A (en) | Single-source metalloorganic precursors to produce ii/vi materials | |
| IL99551A0 (en) | Tricyclic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GB2195247B (en) | Transdermal laminated pharmaceutical compositions having prolonged effect and process for the preparation thereof | |
| IL92554A0 (en) | Polyelectrolytes,processes for the preparation thereof,flocculent compositions containing the same,and separation methods utilizing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A4 | Supplementary search report drawn up and despatched | ||
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI LU NL SE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19940617 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19960829 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19980328 |